InspireMD (NSPR) Preferred Stock Liabilities (2017 - 2018)

InspireMD (NSPR) reported Preferred Stock Liabilities of $2.3 million for Q2 2018, up 27.26% quarter-over-quarter from $1.8 million in Q1 2018.

InspireMD (NSPR) Preferred Stock Liabilities (2017 - 2018) Analysis & Trends

InspireMD has reported Preferred Stock Liabilities for 2 years, with the latest figure at $2.3 million in Q2 2018.

For the quarter ending Q2 2018, Preferred Stock Liabilities changed N/A year-over-year to $2.3 million; the trailing twelve-month figure through Jun 2018 stood at $2.3 million (changed N/A YoY), and the FY2017 full-year result was $274000.0, changed N/A from the prior year.
Preferred Stock Liabilities for Q2 2018 stood at $2.3 million, up from $1.8 million in the prior quarter.
The five-year high for Preferred Stock Liabilities was $2.3 million in Q2 2018, with the low at $274000.0 in Q4 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Stock Liabilities (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	-
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	-
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	-
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	-
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	-
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	-
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	-
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	-
10	InspireMD	45.74 Mn	-8.48 Mn	1.18 Mn	-

Download Data